HDAC9 and neoplasm: Furthermore, the observed acute thymic involution following Entinostat treatment, also described in the non-clinical safety assessment of another HDACi Vorinostat [54], raises questions about the systemic effects of HDAC inhibition on the tumor microenvironment and immune-cell compartments.